"convalescent-plasma"

CPT did not lead to reduction in progression to severe Covid-19 or all-cause mortality in the group that received CPT as compared to the group that did not receive the therapy, said ICMR study

Researchers explore possibility of utilising antiserum derived from the animals as a therapeutic in Covid treatment

The spike protein of SARS-CoV-2 plays a crucial role in helping the virus grab and invade host cells.

"The trial, known as ACTIV-1 Immune Modulators, will determine if the therapeutics are able to restore balance to an overactive immune system."